Showing 1 - 5 results of 5 for search 'Ulrike Kämmerer', query time: 0.03s Refine Results
  1. 1
    Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis.

    Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis. by Rainer J Klement, Colin E Champ, Christoph Otto, Ulrike Kämmerer

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions

    Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions by Sebastian Kuger, Emre Cörek, Bülent Polat, Ulrike Kämmerer, Michael Flentje, Cholpon S. Djuzenova

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Impact of a ketogenic diet intervention during radiotherapy on body composition: III—final results of the KETOCOMP study for breast cancer patients

    Impact of a ketogenic diet intervention during radiotherapy on body composition: III—final results of the KETOCOMP study for breast cancer patients by Rainer J. Klement, Colin E. Champ, Ulrike Kämmerer, Petra S. Koebrunner, Kelley Krage, Gabriele Schäfer, M. Weigel, Reinhart A. Sweeney

    Published 2020-08-01
    Get full text
    Article
  4. 4
    The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic

    The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic by Theresa Hübner, Tanja Wolfgang, Ann-Catrin Theis, Magdalena Steber, Lea Wiedenmann, Achim Wöckel, Joachim Diessner, Grit Hein, Marthe Gründahl, Ulrike Kämmerer, Sarah Kittel-Schneider, Catharina Bartmann

    Published 2022-09-01
    Get full text
    Article
  5. 5
    Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation

    Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation by Catharina Bartmann, Sudha R. Janaki Raman, Jessica Flöter, Almut Schulze, Katrin Bahlke, Jana Willingstorfer, Maria Strunz, Achim Wöckel, Rainer J. Klement, Michaela Kapp, Cholpon S. Djuzenova, Christoph Otto, Ulrike Kämmerer

    Published 2018-06-01
    Get full text
    Article

Search Tools: